SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 11–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380384.
  • 2
    Antolin E, Comas C, Torrents M, Munoz A, Figueras F, Echevarria M, Cararach M, Carrera JM. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10–16 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 295300.
  • 3
    Murta CG, Moron AF, Avila MA, Weiner CP. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002; 17: 308314.
  • 4
    Zoppi MA, Putzolu M, Ibba RM, Floris M, Monni G. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002; 17: 5257.
  • 5
    Borrell A, Martinez JM, Seres A, Borobio V, Cararach V, Fortuny A. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenat Diagn 2003; 23: 921926.
  • 6
    Toyama JM, Brizot ML, Liao AW, Lopes LM, Nomura RM, Saldanha FA, Zugaib M. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004; 23: 341345.
  • 7
    Prefumo F, Sethna F, Sairam S, Bhide A, Thilaganathan B. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population. Obstet Gynecol 2005; 105: 13481354.
  • 8
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Lancet 1998; 352: 343346.
  • 9
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221226.
  • 10
    Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal NT, fetal heart rate, free β hCG and PAPP-A. Hum Reprod 2008; 23: 19681975.
  • 11
    Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH. Learning curve for Doppler assessment of ductus venosus flow at 11–13 + 6 weeks. Ultrasound Obstet Gynecol 2008; 31: 503506.
  • 12
    Office for National Statistics. Birth Statistics. Review of the Registrar General on births and patterns of family building in England and Wales. 2000–2002. Series FM1, number 29–31. Stationery Office: London.
  • 13
    Campbell S, Platt L. The publishing of papers on first-trimester Doppler. Ultrasound Obstet Gynecol 1999; 14: 159160.
  • 14
    Davies P, Dewar J, Tynan M, Ward R. Post-natal developmental changes in the length tension relationship of cat papillary muscles. J Physiol 1975; 253: 95102.
  • 15
    Kaufman TM, Horton JW, White J, Mahony L. Age-related changes in myocardial relaxation and sarcoplasmic reticulum function. Am J Physiol 1990; 259: H309H316.
  • 16
    van Splunder P, Stijnen T, Wladimiroff J. Fetal atrioventricular flow-velocity waveforms and their relation to arterial and venous flow-velocity waveforms at 8 to 20 weeks of gestation. Circulation 1996; 94: 13721373.
  • 17
    Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307310.
  • 18
    Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH. Screening for adverse pregnancy outcome by Ductus venosus Doppler at 11–13+6 weeks. Obstet Gynecol 2008; 112: 598605.
  • 19
    Poon LCY, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregancy-associated plasma protein-A and preeclampsia. Ultrasound Obstet Gynecol 2009; 33: 2333.
  • 20
    Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 1519.
  • 21
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 27: 151155.
  • 22
    Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006; 195: 109114.